The JUPITER trial results boost the evidence for the use of hsCRP as a treatment target and as part of the assessment of vascular risk: time for new guidelines?
| Title | The JUPITER trial results boost the evidence for the use of hsCRP as a treatment target and as part of the assessment of vascular risk: time for new guidelines? |
| Publication Type | Journal Article |
| Year of Publication | 2009 |
| Authors | Athyros, V. G., Tziomalos K., Karagiannis A., & Mikhailidis D. P. |
| Journal | Hellenic J Cardiol |
| Volume | 50 |
| Issue | 2 |
| Pagination | 89-91 |
| Date Published | 2009 Mar-Apr |
| ISSN | 1109-9666 |
| Keywords | C-Reactive Protein, Clinical Trials as Topic, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Incidence, Male, Middle Aged, Practice Guidelines as Topic, Prognosis, Risk Assessment, Risk Factors, United States, Vascular Diseases |
| Alternate Journal | Hellenic J Cardiol |
| PubMed ID | 19329409 |
